top of page

INSIGHTS
Search


Ensuring Access to Life-Saving Medicines: The Case for Compulsory Licensing in Rare Diseases
Rare diseases pose some of the gravest challenges in healthcare. Though uncommon individually, they collectively affect millions of people worldwide. Often these diseases require specialized, lifelong treatments that come with exorbitant price tags. In India, patients suffering from conditions such as spinal muscular atrophy (SMA), haemophilia, thalassemia, and others face tremendous hurdles obtaining affordable medicines. This has placed compulsory licensing, a legal provisi
5 days ago5 min read


FRAND Licensing Dynamics in Southeast Asia 2025: SEP Battlegrounds and Policy Responses
Introduction: The Evolving Role of FRAND in Southeast Asia’s Tech Landscape The Changing FRAND Side of the Southeast Asian tech picture....
Oct 66 min read


Vietnam’s Specialized IP Courts Launch in 2025: Navigating Jurisdictional Reforms and Their Effects on Foreign Pharma Patent Disputes
Introduction Across South Asia, governments are upgrading intellectual property (IP) rules to attract investment and support innovation....
Sep 135 min read


Blockchain-Based IP Licensing in India’s 2025 Semiconductor Growth: Benefits and Challenges
Introduction India is steadily advancing in the global semiconductor race. The nation is channeling large-scale investments into the chip...
Sep 125 min read
bottom of page


